Immunomesh: Device to Improve Cell Production in Immunotherapy
Unmet Medical Need: Cellular therapies hold great promise in treating cancer patients, but current T cell immunotherapy faces limitations in production and performance.
Envisioned Healthcare Product: The envisioned device addresses key limitation of current strategies by providing a better cell expansion and improved cell production system, thus reducing the steps needed for immunotherapy production and improving the performance of the cell product.
Stage of Development: Preliminary studies and direct comparison with the gold standard.
Columbia-Coulter Funding Cycle: 2014-2015